RhumbLine Advisers’s Astria Therapeutics ATXS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $406K | Buy |
75,674
+11,663
| +18% | +$62.5K | ﹤0.01% | 2814 |
|
|
2025
Q1 | $342K | Buy |
64,011
+1,848
| +3% | +$9.87K | ﹤0.01% | 2814 |
|
|
2024
Q4 | $556K | Buy |
62,163
+1,381
| +2% | +$12.3K | ﹤0.01% | 2617 |
|
|
2024
Q3 | $669K | Sell |
60,782
-4,593
| -7% | -$50.6K | ﹤0.01% | 2514 |
|
|
2024
Q2 | $595K | Buy |
65,375
+2,556
| +4% | +$23.3K | ﹤0.01% | 2554 |
|
|
2024
Q1 | $884K | Buy |
62,819
+25,209
| +67% | +$355K | ﹤0.01% | 2320 |
|
|
2023
Q4 | $289K | Buy |
37,610
+5,811
| +18% | +$44.6K | ﹤0.01% | 2997 |
|
|
2023
Q3 | $237K | Buy |
31,799
+1,667
| +6% | +$12.4K | ﹤0.01% | 3061 |
|
|
2023
Q2 | $251K | Buy |
+30,132
| New | +$251K | ﹤0.01% | 3114 |
|
|
2021
Q2 | – | Sell |
-3,524
| Closed | -$61K | – | 2993 |
|
|
2021
Q1 | $61K | Hold |
3,524
| – | – | ﹤0.01% | 2969 |
|
|
2020
Q4 | $45K | Buy |
3,524
+1,261
| +56% | +$16.1K | ﹤0.01% | 3024 |
|
|
2020
Q3 | $84K | Sell |
2,263
-356
| -14% | -$13.2K | ﹤0.01% | 2894 |
|
|
2020
Q2 | $101K | Buy |
+2,619
| New | +$101K | ﹤0.01% | 2965 |
|